Found: 21
Select item for more details and to access through your institution.
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 1980, doi. 10.3390/cancers15071980
- By:
- Publication type:
- Article
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/1756-9966-33-30
- By:
- Publication type:
- Article
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 3176, doi. 10.3390/cells11193176
- By:
- Publication type:
- Article
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919848872
- By:
- Publication type:
- Article
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919848872
- By:
- Publication type:
- Article
Diagnostic and prognostic value of magnetic resonance imaging in the detection of tumor depth of invasion and bone invasion in patients with oral cavity cancer.
- Published in:
- La Radiologia Medica, 2022, v. 127, n. 12, p. 1364, doi. 10.1007/s11547-022-01565-7
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-116
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231151845
- By:
- Publication type:
- Article
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 105, n. 3, p. 267, doi. 10.1007/s10549-006-9456-9
- By:
- Publication type:
- Article
Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 675, doi. 10.1007/s00262-014-1545-8
- By:
- Publication type:
- Article
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program.
- Published in:
- Current Oncology, 2022, v. 29, n. 9, p. 6635, doi. 10.3390/curroncol29090521
- By:
- Publication type:
- Article
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience.
- Published in:
- Oncology, 2020, v. 98, n. 7, p. 445, doi. 10.1159/000505486
- By:
- Publication type:
- Article
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1414343
- By:
- Publication type:
- Article
Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049878
- By:
- Publication type:
- Article
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 6, p. 979, doi. 10.3390/diagnostics11060979
- By:
- Publication type:
- Article
Characteristics of Real-World Patients with High-Risk BRAF<sup>V600E/K</sup>-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
- Published in:
- Cancer Management & Research, 2023, v. 15, p. 1271, doi. 10.2147/CMAR.S423970
- By:
- Publication type:
- Article
Assessment of “grading” with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy.
- Published in:
- Journal of Cellular Physiology, 2009, v. 221, n. 2, p. 343, doi. 10.1002/jcp.21858
- By:
- Publication type:
- Article
TP53 and p16<sup>INK4A</sup>, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas<FNR></FNR><FN>Claudia Augello and Valter Gregori have contributed equally to this work. </FN>.
- Published in:
- Journal of Cellular Physiology, 2006, v. 207, n. 3, p. 654, doi. 10.1002/jcp.20601
- By:
- Publication type:
- Article
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 789, doi. 10.1007/s11523-021-00850-1
- By:
- Publication type:
- Article